Thursday, May 30, 2019

Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib

Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib The settlement allows Natco and its partner Breckenridge to launch the generic version of Kyprolos in 2027 or sooner depending on certain occurrences.

from Moneycontrol Business News http://bit.ly/30TCpWv

No comments:

Post a Comment

GMR Airports shares rise 3% as company swings to black with Rs 202 crore profit in Q3

GMR Airports share price: GMR Airports shares gained 3% on news of significant profit for Q3 FY25, driven by increased passenger traffic and...